Cardiac fibrosis
Open accessThe DOI matches its Crossref record; 612 of the 615 references it cites were found in a registry or an index.
Abstract
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of extracellular matrix proteins, is a common pathophysiologic companion of many different myocardial conditions. Fibrosis may reflect activation of reparative or maladaptive processes. Activated fibroblasts and myofibroblasts are the central cellular effectors in cardiac fibrosis, serving as the main source of matrix proteins. Immune cells, vascular cells and cardiomyocytes may also acquire a fibrogenic phenotype under conditions of stress, activating fibroblast populations. Fibrogenic growth factors (such as transforming growth factor-β and platelet-derived growth factors), cytokines [including tumour necrosis factor-α, interleukin (IL)-1, IL-6, IL-10, and IL-4], and neurohumoral pathways trigger fibrogenic signalling cascades through binding to surface receptors, and activation of downstream signalling cascades. In addition, matricellular macromolecules are deposited in the remodelling myocardium and regulate matrix assembly, while modulating signal transduction cascades and protease or growth factor activity. Cardiac fibroblasts can also sense mechanical stress through mechanosensitive receptors, ion channels and integrins, activating intracellular fibrogenic cascades that contribute to fibrosis in response to pressure overload. Although subpopulations of fibroblast-like cells may exert important protective actions in both reparative and interstitial/perivascular fibrosis, ultimately fibrotic changes perturb systolic and diastolic function, and may play an important role in the pathogenesis of arrhythmias. This review article discusses the molecular mechanisms involved in the pathogenesis of cardiac fibrosis in various myocardial diseases, including myocardial infarction, heart failure with reduced or preserved ejection fraction, genetic cardiomyopathies, and diabetic heart disease. Development of fibrosis-targeting therapies for patients with myocardial diseases will require not only understanding of the functional pluralism of cardiac fibroblasts and dissection of the molecular basis for fibrotic remodelling, but also appreciation of the pathophysiologic heterogeneity of fibrosis-associated myocardial disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction1,2.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [2]
In the citing paper
“Among stromal cell types, fibroblasts are of particular interest given their role in tissue fibrosis, arrhythmias, and heart failure 16,29,30 .”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [30]
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495 · cited 1×
“Fibrosis is an important cause of organ dysfunction in many different diseases, including interstitial lung diseases, liver cirrhosis, progressive systemic sclerosis, and diabetic nephropathy.(1)”
BackgroundMyofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Self-citationEndothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222 · cited 2×
“The antifibrotic effects were attributed to blockade of TGF-b signalling and were associated with attenuated endothelial to mesenchymal transition.(22,247) Moreover, gain-of-function studies have”
BackgroundHinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Seto, E., & Yoshida, M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018713 · Cited by 1,989
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Reimer, K. A., Lowe, J. E., Rasmussen, M. M., & Jennings, R. B. (1977) · Circulation · doi:10.1161/01.cir.56.5.786 · Cited by 1,944
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
The inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
Self-citationFormation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658 · cited 1×
“stressed hearts, fibroblasts undergo conversion to myofibroblasts, cells that exhibit a prominent endoplasmic reticulum (indicating a synthetically active phenotype), while expressing contractile proteins, such as asmooth muscle actin (a-SMA).(36,37) Infiltration of the heart with activated myofibroblasts has been rep…”
BackgroundMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Epelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.019 · Cited by 1,494
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427 · cited 1×
“In vitro studies have demonstrated that angiotensin II stimulates cardiac fibroblast proliferation,(75) inhibits fibroblast apoptosis,(76) stimulates fibroblast migration(77,78) inducing integrin expression,(79) promotes myofibroblast conversion,(80) and markedly increases synthesis of structural ECM proteins.(81,82)…”
BackgroundRevisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · cited 1×
“Vascular endothelial cells are the most abundant noncardiomyocytes in adult mouse hearts, reflecting the rich microvasculature of the myocardium.(9) Smaller populations of immune cells (macrophages, mast cells, and dendritic cells), and vascular mural cells (smooth muscle cells and pericytes) are also found in the nor…”
BackgroundSadoshima, J.-I., Xu, Y., Slayter, H. S., & Izumo, S. (1993) · Cell · doi:10.1016/0092-8674(93)90541-w · Cited by 1,348
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346 · cited 1×
“The antifibrotic effects were attributed to blockade of TGF-b signalling and were associated with attenuated endothelial to mesenchymal transition.(22,247) Moreover, gain-of-function studies have”
BackgroundTransforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278 · cited 1×
“1 TGF-bs in cardiac fibrosis TGF-b is the best characterized fibrogenic growth factor.(210,211) In mammals, the TGF-b subfamily is comprised of three isoforms (TGF-b1, 2, and 3)(212) that signal through the same receptors and share common cel-”
BackgroundSelf-citationProteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
Obokata, M., Reddy, Y. N. V., Pislaru, S. V., Melenovsky, V., & Borlaug, B. A. (2017) · Circulation · doi:10.1161/circulationaha.116.026807 · Cited by 1,179
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120 · cited 1×
“Resident cardiac fibroblasts may serve to maintain the structural integrity of the matrix network,(16) regulating collagen turnover, a process that requires ongoing synthesis and degradation of ECM proteins.(17,18) Fibroblast-specific baseline activation of Smad3 signal-”
BackgroundKagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Cardiac interstitium in health and disease: The fibrillar collagen network
Weber, K. T. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90360-4 · Cited by 1,056
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044 · cited 1×
“In the pressureoverloaded myocardium, IL-33 was found to exert cardioprotective and anti-fibrotic actions, attributed to its binding to the ST2 receptor in cardiomyocytes and fibroblasts.(177) However, considering the potent effects of the IL-33/ST2 axis on cardiomyocytes, macrophages and lymphocytes, whether the prot…”
BackgroundLatent TGF-β structure and activation
Shi, M., Zhu, J., Wang, R., Chen, X., Mi, L., Walz, T., & Springer, T. A. (2011) · Nature · doi:10.1038/nature10152 · Cited by 1,013
Bang, C., Batkai, S., Dangwal, S., Gupta, S. K., Foinquinos, A., Holzmann, A., Just, A., Remke, J., Zimmer, K., Zeug, A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70577 · Cited by 979
Norman, C., Runswick, M., Pollock, R., & Treisman, R. (1988) · Cell · doi:10.1016/0092-8674(88)90244-9 · Cited by 957
Sharma, U. C., Pokharel, S., van Brakel, T. J., van Berlo, J. H., Cleutjens, J. P. M., Schroen, B., André, S., Crijns, H. J. G. M., Gabius, H. J., Maessen, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147181.65298.4d · Cited by 947
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Structural and functional characterisation of cardiac fibroblasts
CAMELLITI, P., BORG, T., & KOHL, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.020 · Cited by 930 · cited 1×
“Cardiac fibroblasts, the main matrix-producing cells, form one of the largest cell populations in normal mammalian hearts and are typically enmeshed in the endomysium and perimysium.(14,15) The abundance of fibroblasts in uninjured hearts may suggest an important homeostatic role; however, the functions of cardiac fib…”
BackgroundPerivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis
Kramann, R., Schneider, R. K., DiRocco, D. P., Machado, F., Fleig, S., Bondzie, P. A., Henderson, J. M., Ebert, B. L., & Humphreys, B. D. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.004 · Cited by 922
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94753 · Cited by 905
ECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902 · cited 1×
“Myocardial fibrosis, the expansion of the cardiac interstitium due to net accumulation of ECM proteins, accompanies most cardiac pathologic conditions.(2,3) Although in most myocardial diseases, the extent of car-”
BackgroundGenetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
Serini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.873 · Cited by 847
Senbanjo, L. T., & Chellaiah, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00018 · Cited by 842
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841 · cited 1×
“Myocardial fibrosis, the expansion of the cardiac interstitium due to net accumulation of ECM proteins, accompanies most cardiac pathologic conditions.(2,3) Although in most myocardial diseases, the extent of car-”
BackgroundSelf-citationTargeting cardiac fibrosis with engineered T cells
Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1546-z · Cited by 801
Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., & Sorescu, D. (2005) · Circulation Research · doi:10.1161/01.res.0000187457.24338.3d · Cited by 786
Evidence for Cardiomyopathy in Familial Diabetes Mellitus
Regan, T. J., Lyons, M. M., Ahmed, S. S., Levinson, G. E., Oldewurtel, H. A., Ahmad, M. R., & Haider, B. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108843 · Cited by 728
Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L., & Frangogiannis, N. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163017.13772.3a · Cited by 719 · cited 1×
“of monocytes and macrophages expressing the main CCL2 receptor, CCR2, resulting in up-regulation of fibrogenic mediators, such as TGF-b and osteopontin.(128,129,137) Although CCL2 has been suggested to pro-”
BackgroundSelf-citationThe human heart contains distinct macrophage subsets with divergent origins and functions
Bajpai, G., Schneider, C., Wong, N., Bredemeyer, A., Hulsmans, M., Nahrendorf, M., Epelman, S., Kreisel, D., Liu, Y., Itoh, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0059-x · Cited by 712
Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis
Weidemann, F., Herrmann, S., Störk, S., Niemann, M., Frantz, S., Lange, V., Beer, M., Gattenlöhner, S., Voelker, W., Ertl, G., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.847772 · Cited by 706
The myofibroblast: Paradigm for a mechanically active cell
Hinz, B. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.09.020 · Cited by 698 · cited 1×
“stressed hearts, fibroblasts undergo conversion to myofibroblasts, cells that exhibit a prominent endoplasmic reticulum (indicating a synthetically active phenotype), while expressing contractile proteins, such as asmooth muscle actin (a-SMA).(36,37) Infiltration of the heart with activated myofibroblasts has been rep…”
BackgroundMyocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Ho, C. Y., López, B., Coelho-Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolim, P., Kwong, R., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 696
Brilla, C. G., Zhou, G., Matsubara, L., & Weber, K. T. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1098 · Cited by 694
Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II
Zou, Y., Akazawa, H., Qin, Y., Sano, M., Takano, H., Minamino, T., Makita, N., Iwanaga, K., Zhu, W., Kudoh, S., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1137 · Cited by 683 · cited 1×
“ways require angiotensin II stimulation but may be directly activated by mechanical stress, stimulating a hypertrophic response.(95) Whether”
BackgroundSiwik, D. A., Pagano, P. J., & Colucci, W. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c53 · Cited by 674
Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.158 · Cited by 673
Leask, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.217737 · Cited by 667
Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease
Brilla, C. G., Funck, R. C., & Rupp, H. (2000) · Circulation · doi:10.1161/01.cir.102.12.1388 · Cited by 649
THE CARDIAC FIBROBLAST: Therapeutic Target in Myocardial Remodeling and Failure
Brown, R. D., Ambler, S. K., Mitchell, M. D., & Long, C. S. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095802 · Cited by 647 · cited 1×
“Resident cardiac fibroblasts may serve to maintain the structural integrity of the matrix network,(16) regulating collagen turnover, a process that requires ongoing synthesis and degradation of ECM proteins.(17,18) Fibroblast-specific baseline activation of Smad3 signal-”
BackgroundIL-11 is a crucial determinant of cardiovascular fibrosis
Schafer, S., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Moreno-Moral, A., DeLaughter, D. M., Ng, B., Patone, G., Chow, K., Khin, E., et al. (2017) · Nature · doi:10.1038/nature24676 · Cited by 639
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart
Fu, X., Khalil, H., Kanisicak, O., Boyer, J. G., Vagnozzi, R. J., Maliken, B. D., Sargent, M. A., Prasad, V., Valiente-Alandi, I., Blaxall, B. C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98215 · Cited by 636
Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630
Jugdutt, B. I. (2003) · Circulation · doi:10.1161/01.cir.0000085658.98621.49 · Cited by 629
Johannes, L., Jacob, R., & Leffler, H. (2018) · Journal of Cell Science · doi:10.1242/jcs.208884 · Cited by 618
Kuwahara, F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2002) · Circulation · doi:10.1161/01.cir.0000020689.12472.e0 · Cited by 609
Rollins, B. J. (1997) · PubMed · Cited by 603
Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α
Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M., & Giroir, B. (1998) · Circulation · doi:10.1161/01.cir.97.14.1375 · Cited by 600
de Boer, R. A., Lok, D. J. A., Jaarsma, T., van der Meer, P., Voors, A. A., Hillege, H. L., & van Veldhuisen, D. J. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.538080 · Cited by 592
The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling
Shinde, A. V., Humeres, C., & Frangogiannis, N. G. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.006 · Cited by 577 · cited 1×
“Identification and characterization of fibroblast populations is further complicated by their dynamic phenotypic alterations in injured tissues.(35) In infarcted and”
BackgroundSelf-citationCardiac Fibrosis in Patients With Atrial Fibrillation
Dzeshka, M. S., Lip, G. Y. H., Snezhitskiy, V., & Shantsila, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1313 · Cited by 552
Collagen remodeling after myocardial infarction in the rat heart.
Cleutjens, J. P. M., Verluyten, M. J., Smiths, J. F., & Daemen, M. J. A. P. (1995) · Europe PMC (PubMed Central) · Cited by 550
Farbehi, N., Patrick, R., Dorison, A., Xaymardan, M., Janbandhu, V., Wystub-Lis, K., Ho, J. W., Nordon, R. E., & Harvey, R. P. (2019) · eLife · doi:10.7554/elife.43882 · Cited by 549 · cited 4×
“scripts encoding proteins with anti-fibrotic properties, such as the matricellular gene Wisp/CCN5 and the Wnt antagonist Sfrp.(21) Whether these transcriptomic profiles are associated with pro- vs.”
BackgroundInfluentialDobaczewski, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.015 · Cited by 548 · cited 1×
“interacting with specific functional domains of ECM macromolecules.(65,289)”
BackgroundSelf-citationRegulation of Alternative Macrophage Activation by Galectin-3
MacKinnon, A. C., Farnworth, S. L., Hodkinson, P. S., Henderson, N. C., Atkinson, K. M., Leffler, H., Nilsson, U. J., Haslett, C., Forbes, S. J., & Sethi, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2650 · Cited by 543
Chemotactic activity of elastin-derived peptides.
Senior, R. M., Griffin, G. L., & Mecham, R. P. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109926 · Cited by 532
Siwik, D. A., Chang, D. L.-F., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1259 · Cited by 517
Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Smith, E. D., Lakdawala, N. K., Papoutsidakis, N., Aubert, G., Mazzanti, A., McCanta, A. C., Agarwal, P. P., Arscott, P., Dellefave-Castillo, L. M., Vorovich, E. E., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044934 · Cited by 504
Khan, R., & Sheppard, R. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02336.x · Cited by 501
Tandri, H., Saranathan, M., Rodriguez, E. R., Martinez, C., Bomma, C., Nasir, K., Rosen, B., Lima, J. A. C., Calkins, H., & Bluemke, D. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.053 · Cited by 497
Oka, T., Xu, J., Kaiser, R. A., Melendez, J., Hambleton, M., Sargent, M. A., Lorts, A., Brunskill, E. W., Dorn, G. W., Conway, S. J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.149047 · Cited by 494
Cardiac macrophages promote diastolic dysfunction
Hulsmans, M., Sager, H. B., Roh, J. D., Valero-Muñoz, M., Houstis, N. E., Iwamoto, Y., Sun, Y., Wilson, R. M., Wojtkiewicz, G., Tricot, B., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171274 · Cited by 494 · cited 1×
“In a model of cardiac remodelling induced through unilateral nephrectomy, salt loading and aldosterone infusion, IL-10 was found to critically contribute to fibroblast activation and to the pathogenesis of diastolic dysfunction.(206) The fibro-”
BackgroundWong, T. C., Piehler, K., Meier, C. G., Testa, S. M., Klock, A. M., Aneizi, A. A., Shakesprere, J., Kellman, P., Shroff, S. G., Schwartzman, D. S., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.089409 · Cited by 493
Tissue Transglutaminase Is an Integrin-Binding Adhesion Coreceptor for Fibronectin
Akimov, S. S., Krylov, D., Fleischman, L. F., & Belkin, A. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.825 · Cited by 490
Calderone, A., Thaik, C. M., Takahashi, N., Chang, D. L., & Colucci, W. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119883 · Cited by 490
Biernacka, A., & Frangogiannis, N. G. (2011) · Europe PMC (PubMed Central) · Cited by 484
Self-citationRegulation of collagen degradation in the rat myocardium after infarction
CLEUTJENS, J., KANDALA, J., GUARDA, E., GUNTAKA, R., & WEBER, K. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(05)82390-9 · Cited by 479 · cited 1×
“elling by producing proteases, such as matrix metalloproteinases (MMPs), and their inhibitors.(34) The expansion and activation of fibro-”
BackgroundRusso, I., & Frangogiannis, N. G. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.011 · Cited by 474
Self-citationSchiller, M., Javelaud, D., & Mauviel, A. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2003.12.006 · Cited by 468
Mori, T., Kawara, S., Shinozaki, M., Hayashi, N., Kakinuma, T., Igarashi, A., Takigawa, M., Nakanishi, T., & Takehara, K. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199910)181:1<153::aid-jcp16>3.0.co;2-k · Cited by 468 · cited 1×
“gested that TGF-b-mediated fibrosis may require downstream release of the matricellular protein CCN2/connective tissue growth factor.(241) However, experiments using both loss- and gain-of-function approaches”
BackgroundYAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis
Szeto, S. G., Narimatsu, M., Lu, M., He, X., Sidiqi, A. M., Tolosa, M. F., Chan, L., De Freitas, K., Bialik, J. F., Majumder, S., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050499 · Cited by 462
Periostin is essential for cardiac healingafter acute myocardial infarction
Shimazaki, M., Nakamura, K., Kii, I., Kashima, T., Amizuka, N., Li, M., Saito, M., Fukuda, K., Nishiyama, T., Kitajima, S., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071297 · Cited by 461
TGF-β1 – A truly transforming growth factor in fibrosis and immunity
Lodyga, M., & Hinz, B. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 458 · cited 1×
“1 TGF-bs in cardiac fibrosis TGF-b is the best characterized fibrogenic growth factor.(210,211) In mammals, the TGF-b subfamily is comprised of three isoforms (TGF-b1, 2, and 3)(212) that signal through the same receptors and share common cel-”
BackgroundFlick, M. J., Du, X., Witte, D. P., Jiroušková, M., Soloviev, D. A., Busuttil, S. J., Plow, E. F., & Degen, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20741 · Cited by 450
Conrad, C. H., Brooks, W. W., Hayes, J. A., Sen, S., Robinson, K. G., & Bing, O. H. L. (1995) · Circulation · doi:10.1161/01.cir.91.1.161 · Cited by 447
Matricellular Proteins in Cardiac Adaptation and Disease
Frangogiannis, N. G. (2012) · Physiological Reviews · doi:10.1152/physrev.00008.2011 · Cited by 445 · cited 1×
“interacting with specific functional domains of ECM macromolecules.(65,289)”
BackgroundSelf-citationRegulation of TGF-β Family Signaling by Inhibitory Smads
Miyazawa, K., & Miyazono, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022095 · Cited by 439
Gharaee-Kermani, M., Denholm, E. M., & Phan, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17779 · Cited by 435
Yu, L., Ruifrok, W. P. T., Meissner, M., Bos, E. M., van Goor, H., Sanjabi, B., van der Harst, P., Pitt, B., Goldstein, I. J., Koerts, J. A., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.971168 · Cited by 435
The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis
Steen, E. H., Wang, X., Balaji, S., Butte, M. J., Bollyky, P. L., & Keswani, S. G. (2020) · Advances in Wound Care · doi:10.1089/wound.2019.1032 · Cited by 433
Schieffer, B., Wirger, A., Meybrunn, M., Seitz, S., Holtz, J., Riede, U. N., & Drexler, H. (1994) · Circulation · doi:10.1161/01.cir.89.5.2273 · Cited by 420
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.
Schorb, W., Booz, G. W., Dostal, D. E., Conrad, K. M., Chang, K. C., & Baker, K. M. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1245 · Cited by 391
Negative regulation of TGF-β receptor/Smad signal transduction
Itoh, S., & ten Dijke, P. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.015 · Cited by 388
The alpha-smooth muscle actin-positive cells in healing human myocardial scars.
WILLEMS, I. E. M. G., Havenith, M. G., Mey, J. G. R. D., & Daemen, M. J. A. P. (1994) · PubMed Central · Cited by 385
Widyantoro, B., Emoto, N., Nakayama, K., Anggrahini, D. W., Adiarto, S., Iwasa, N., Yagi, K., Miyagawa, K., Rikitake, Y., Suzuki, T., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.938217 · Cited by 385 · cited 1×
“EndMT has been suggested to contribute to the myocardial fibrotic response.(287) Unfortunately, the evidence supporting this specific cellular mechanism was limited to dual staining with non-specific markers for fibroblasts and endothelial cells.”
BackgroundDobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.216101 · Cited by 385 · cited 2×
“Some studies have reported that TGF-b stimulates proliferation of cardiac fibroblasts,(235) whereas other investigations demonstrated anti-proliferative effects.(231,236) The contrasting findings likely reflect differences in the state of differentiation of fibroblast populations,(237) the presence or absence of other…”
BackgroundSelf-citationLeft Atrial Reverse Remodeling
Thomas, L., & Abhayaratna, W. P. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2016.11.003 · Cited by 385
Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis
Treibel, T. A., Kozor, R., Schofield, R., Benedetti, G., Fontana, M., Bhuva, A. N., Sheikh, A., López, B., González, A., Manisty, C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.035 · Cited by 384
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643585 · Cited by 383
Dewald, O., Ren, G., Duerr, G. D., Zoerlein, M., Klemm, C., Gersch, C., Tincey, S., Michael, L. H., Entman, M. L., & Frangogiannis, N. G. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63154-9 · Cited by 382
Self-citationSivasubramanian, N., Coker, M. L., Kurrelmeyer, K. M., MacLellan, W. R., DeMayo, F. J., Spinale, F. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/hc3401.093154 · Cited by 382 · cited 1×
“suggests that early protease-mediated matrix degradation is followed by late up-regulation of TGF-bs and activation of a matrix-preserving programme.(155) Experiments using loss-of-function models have implicated”
BackgroundMitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-β Signaling
Jain, M., Rivera, S., Monclus, E. A., Synenki, L., Zirk, A., Eisenbart, J., Feghali-Bostwick, C., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431973 · Cited by 381
Small, E. M., Thatcher, J. E., Sutherland, L. B., Kinoshita, H., Gerard, R. D., Richardson, J. A., DiMaio, J. M., Sadek, H., Kuwahara, K., & Olson, E. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223172 · Cited by 373
Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
Bujak, M., Dobaczewski, M., Chatila, K., Mendoza, L. H., Li, N., Reddy, A., & Frangogiannis, N. G. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070974 · Cited by 365 · cited 11×
“Although myeloid cell-specific loss of Smad3 markedly attenuated TGF-b synthesis by macrophages, collagen deposition in the infarct and interstitial fibrosis in non-infarcted areas was not affected in a model of non-reperfused MI.243 5.4.2 Other members of the TGF-b superfamily Information on the role of other members…”
BackgroundInfluentialSelf-citationMulder, P., Richard, V., Derumeaux, G., Hogie, M., Henry, J. P., Lallemand, F., Compagnon, P., Macé, B., Comoy, E., Letac, B., et al. (1997) · Circulation · doi:10.1161/01.cir.96.6.1976 · Cited by 360 · cited 1×
“In experimental animal models of hypertensive heart disease and of reparative myocardial fibrosis, ET-1 inhibition reduced fibrotic remodelling.(280,281)”
BackgroundControl of cellular responses to mechanical cues through YAP/TAZ regulation
Dasgupta, I., & McCollum, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007963 · Cited by 360
A TRPC6-Dependent Pathway for Myofibroblast Transdifferentiation and Wound Healing In Vivo
Davis, J., Burr, A. R., Davis, G. F., Birnbaumer, L., & Molkentin, J. D. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.017 · Cited by 358
Campbell, S. E., & Katwa, L. C. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0435 · Cited by 357
Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling
Bujak, M., Ren, G., Kweon, H. J., Dobaczewski, M., Reddy, A., Taffet, G., Wang, X.-F., & Frangogiannis, N. G. (2007) · Circulation · doi:10.1161/circulationaha.107.704197 · Cited by 356
Self-citationThe long noncoding RNA Wisper controls cardiac fibrosis and remodeling
Micheletti, R., Plaisance, I., Abraham, B. J., Sarre, A., Ting, C.-C., Alexanian, M., Maric, D., Maison, D., Nemir, M., Young, R. A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai9118 · Cited by 349
Piccoli, M.-T., Gupta, S. K., Viereck, J., Foinquinos, A., Samolovac, S., Kramer, F. L., Garg, A., Remke, J., Zimmer, K., Batkai, S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310624 · Cited by 344
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis.
Benjamin, I. J., Jalil, J. E., Tan, L. B., Cho, K., Weber, K. T., & Clark, W. A. (1989) · Circulation Research · doi:10.1161/01.res.65.3.657 · Cited by 343
van Hoeven, K. H., & Factor, S. M. (1990) · Circulation · doi:10.1161/01.cir.82.3.848 · Cited by 342
Alternatively activated macrophages determine repair of the infarcted adult murine heart
Shiraishi, M., Shintani, Y., Shintani, Y., Ishida, H., Saba, R., Yamaguchi, A., Adachi, H., Yashiro, K., & Suzuki, K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85782 · Cited by 342
Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice
Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., Pilling, D., Gomer, R. H., Trial, J., Frangogiannis, N. G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608799103 · Cited by 338 · cited 1×
“Some studies have suggested that CCL2 may promote fibrosis by recruiting circulating fibroblast progenitors.(49,50) However, the”
BackgroundSelf-citationKato, M., Wang, H., Kainulainen, V., Fitzgerald, M. L., Ledbetter, S., Ornitz, D. M., & Bernfield, M. (1998) · Nature Medicine · doi:10.1038/nm0698-691 · Cited by 338
TRPM7-Mediated Ca 2+ Signals Confer Fibrogenesis in Human Atrial Fibrillation
Du, J., Xie, J., Zhang, Z., Tsujikawa, H., Fusco, D., Silverman, D., Liang, B., & Yue, L. (2010) · Circulation Research · doi:10.1161/circresaha.109.206771 · Cited by 331
Disertori, M., Rigoni, M., Pace, N., Casolo, G., Masè, M., Gonzini, L., Lucci, D., Nollo, G., & Ravelli, F. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2016.01.033 · Cited by 331
Li, Y. Y., Feng, Y. Q., Kadokami, T., McTiernan, C. F., Draviam, R., Watkins, S. C., & Feldman, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12746 · Cited by 324 · cited 1×
“Transgenic mice with myocardial TNF-a overexpression develop heart failure associated with fibrotic changes.(153,154)”
BackgroundTanaka, K., Zlochiver, S., Vikstrom, K. L., Yamazaki, M., Moreno, J., Klos, M., Zaitsev, A. V., Vaidyanathan, R., Auerbach, D. S., Landas, S., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.153858 · Cited by 319
Duan, J., Gherghe, C., Liu, D., Hamlett, E., Srikantha, L., Rodgers, L., Regan, J. N., Rojas, M., Willis, M., Leask, A., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.418 · Cited by 314 · cited 1×
“Wntmediated fibroblast activation in the injured heart likely involves signalling through the b-catenin pathway.(267,268) Cell-specific genetic loss-offunction studies demonstrated that fibroblast-specific activation of b-catenin mediates both fibrosis and cardiomyocyte hypertrophy in the pressure-overloaded heart.”
BackgroundInterleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Ng, B., Dong, J., D’Agostino, G., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Ko, N. S. J., Tan, J., Chothani, S. P., Huang, B., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1237 · Cited by 314 · cited 1×
“The gp130 cytokine IL-11 has also been suggested to act as a critical downstream signal mediating TGF-b-driven fibrosis not only in the heart(187) but also in other organs.(188,189)”
BackgroundPan, Z., Sun, X., Shan, H., Wang, N., Wang, J., Ren, J., Feng, S., Xie, L., Lu, C., Yuan, Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.094524 · Cited by 312
Ali, S. R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A., Kamran, P., Müller, A. M. S., Volz, K. S., Tang, Z., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303794 · Cited by 309
Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts
Frangogiannis, N. G., Ren, G., Dewald, O., Zymek, P., Haudek, S., Koerting, A., Winkelmann, K., Michael, L. H., Lawler, J., & Entman, M. L. (2005) · Circulation · doi:10.1161/circulationaha.104.510354 · Cited by 308
Self-citationThe role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Self-citationIL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult
Xiao, H., Li, H., Wang, J.-J., Zhang, J.-S., Shen, J., An, X.-B., Zhang, C.-C., Wu, J.-M., Song, Y., Wang, X.-Y., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx261 · Cited by 305
Rickard, A. J., Morgan, J., Tesch, G., Funder, J. W., Fuller, P. J., & Young, M. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.131110 · Cited by 303
Kapoun, A. M., Liang, F., O’Young, G., Damm, D. L., Quon, D., White, R. T., Munson, K., Lam, A., Schreiner, G. F., & Protter, A. A. (2004) · Circulation Research · doi:10.1161/01.res.0000117070.86556.9f · Cited by 302
Aisagbonhi, O., Rai, M., Ryzhov, S., Atria, N., Feoktistov, I., & Hatzopoulos, A. K. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006510 · Cited by 302
Trueblood, N. A., Xie, Z., Communal, C., Sam, F., Ngoy, S., Liaw, L., Jenkins, A. W., Wang, J., Sawyer, D. B., Bing, O. H. L., et al. (2001) · Circulation Research · doi:10.1161/hh1001.090842 · Cited by 300
Rosenkranz, S., Flesch, M., Amann, K., Haeuseler, C., Kilter, H., Seeland, U., Schlüter, K.-D., & Böhm, M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00578.2001 · Cited by 300
Sano, M., Fukuda, K., Sato, T., Kawaguchi, H., Suematsu, M., Matsuda, S., Koyasu, S., Matsui, H., Yamauchi-Takihara, K., Harada, M., et al. (2001) · Circulation Research · doi:10.1161/hh2001.098873 · Cited by 298
Patel, B., Bansal, S. S., Ismahil, M. A., Hamid, T., Rokosh, G., Mack, M., & Prabhu, S. D. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2017.12.006 · Cited by 297
Effects of endothelins on collagen turnover in cardiac fibroblasts
Guarda, E., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291
Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., Kraemer, D., Taffet, G., Rollins, B. J., & Entman, M. L. (2007) · Circulation · doi:10.1161/circulationaha.106.646091 · Cited by 289
Self-citationThe CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
Döring, Y., Pawig, L., Weber, C., & Noels, H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00212 · Cited by 289 · cited 1×
“tory and progenitor cells, and in regulation of cardiomyocyte survival following injury.(144,145) Several studies have suggested that CXCL12 may exert fibrogenic actions through CXCR4 activation.”
BackgroundIL-10 Is Induced in the Reperfused Myocardium and May Modulate the Reaction to Injury
Frangogiannis, N. G., Mendoza, L. H., Lindsey, M. L., Ballantyne, C. M., Michael, L. H., Smith, C. W., & Entman, M. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2798 · Cited by 288 · cited 1×
“with in vitro observations suggesting that IL-10 does not significantly affect fibroblast gene expression profile,(207) but promotes a matrix-preserving phenotype in macrophages through up-regulation of TIMP-1 synthesis.(204) In contrast, other studies suggested that endogenous IL-10 may”
BackgroundSelf-citationWang, L., Zhang, Y.-L., Lin, Q.-Y., Liu, Y., Guan, X.-M., Ma, X.-L., Cao, H.-J., Liu, Y., Bai, J., Xia, Y.-L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy085 · Cited by 288 · cited 1×
“angiotensin-induced cardiac fibrosis through recruitment of a fibrogenic monocyte subpopulation.(143) CXCL12 has a broad range of actions in injured and remodelling”
BackgroundMcLellan, M. A., Skelly, D. A., Dona, M. S. I., Squiers, G. T., Farrugia, G. E., Gaynor, T. L., Cohen, C. D., Pandey, R., Diep, H., Vinh, A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045115 · Cited by 287 · cited 1×
“expressing Cartilage Intermediate layer protein 1 (Cilp) or Thrombospondin-4 (Thbs4) as the predominant fibrogenic cell types, in the absence of a-SMA-expressing myofibroblasts.(45)”
BackgroundMolkentin, J. D., Bugg, D., Ghearing, N., Dorn, L. E., Kim, P., Sargent, M. A., Gunaje, J., Otsu, K., & Davis, J. (2017) · Circulation · doi:10.1161/circulationaha.116.026238 · Cited by 283 · cited 1×
“actions of TGF-b on cardiac fibroblasts may involve activation of Smadindependent p38 MAPK, ERK, or Transforming Growth Factor-b-activated kinase (TAK)1 signalling.(114,239,240) However, considering the wide”
BackgroundHypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation?
Kuwahara, F., Kai, H., Tokuda, K., Takeya, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2004) · Hypertension · doi:10.1161/01.hyp.0000118584.33350.7d · Cited by 282
Anti‐inflammatory therapies in myocardial infarction: failures, hopes and challenges
Huang, S., & Frangogiannis, N. G. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14155 · Cited by 282
Self-citationThe extracellular matrix: At the center of it all
Bowers, S. L. K., Banerjee, I., & Baudino, T. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.024 · Cited by 277 · cited 1×
“These layers of cardiomyocytes are surrounded by an interstitial ECM network, comprised predominantly of fibrillar collagens.(5,6) The cardiac ECM not only serves as a mechanical scaffold but is also important for transmission of contractile force.”
BackgroundLeft Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure
Nevers, T., Salvador, A. M., Grodecki-Pena, A., Knapp, A., Velázquez, F., Aronovitz, M., Kapur, N. K., Karas, R. H., Blanton, R. M., & Alcaide, P. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002225 · Cited by 274
Tallquist, M. D. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034527 · Cited by 272 · cited 3×
“Cardiac fibroblasts, the main matrix-producing cells, form one of the largest cell populations in normal mammalian hearts and are typically enmeshed in the endomysium and perimysium.(14,15) The abundance of fibroblasts in uninjured hearts may suggest an important homeostatic role; however, the functions of cardiac fib…”
BackgroundMechanical force regulation of myofibroblast differentiation in cardiac fibroblasts
Wang, J., Chen, H., Seth, A., & McCulloch, C. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00387.2003 · Cited by 270
Physiological Implications of Myocardial Scar Structure
Richardson, W. J., Clarke, S. A., Quinn, T. A., & Holmes, J. W. (2015) · Comprehensive Physiology · doi:10.1002/cphy.c140067 · Cited by 268
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Yang, J., Savvatis, K., Kang, J. S., Fan, P., Zhong, H., Schwartz, K., Barry, V., Mikels-Vigdal, A., Karpinski, S., Kornyeyev, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13710 · Cited by 268
Cavalera, M., Wang, J., & Frangogiannis, N. G. (2014) · Translational Research · doi:10.1016/j.trsl.2014.05.001 · Cited by 267
Self-citationXia, Y., Lee, K., Li, N., Corbett, D., Mendoza, L., & Frangogiannis, N. G. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0541-5 · Cited by 264
Self-citationWells, J. M., Gaggar, A., & Blalock, J. E. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.016 · Cited by 263 · cited 1×
“Many forms of cardiac injury, including myocardial ischaemia and pressure overload, induce rapid release and activation of proteases that degrade the native ECM, generating bioactive peptides termed matrikines and matricryptins.(290,291) Matrikines are fragments of ECM macromolecules with biological properties distinc…”
BackgroundInduction of Cardiac Fibrosis by Aldosterone
Lijnen, P., & Petrov, V. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1129 · Cited by 263 · cited 1×
“Extensive evidence suggests that aldosterone may play an important role in fibroblast activation following myocardial injury.(96,97) In isolated cardiac fibroblasts, aldosterone triggers a proliferative response,(98) stimulates migration,(99) and promotes a matrix-synthetic phenotype,(100) at least in part through act…”
BackgroundDuan, Q., McMahon, S., Anand, P., Shah, H., Thomas, S., Salunga, H. T., Huang, Y., Zhang, R., Sahadevan, A., Lemieux, M. E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5084 · Cited by 262
Nakajima, H., Nakajima, H. O., Salcher, O., Dittiè, A. S., Dembowsky, K., Jing, S., & Field, L. J. (2000) · Circulation Research · doi:10.1161/01.res.86.5.571 · Cited by 260
Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse
Kitkungvan, D., Nabi, F., Kim, R. J., Bonow, R. O., Khan, M. A., Xu, J., Little, S. H., Quinones, M. A., Lawrie, G. M., Zoghbi, W. A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.048 · Cited by 260
Siwik, D. A., & Colucci, W. S. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011393.40674.13 · Cited by 259
Myocardial Scar and Mortality in Severe Aortic Stenosis: Data From the BSCMR Valve Consortium
Musa, T. A., Treibel, T. A., Vassiliou, V. S., Captur, G., Singh, A., Chin, C., Dobson, L. E., Pica, S., Loudon, M., Malley, T., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032839 · Cited by 255
Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects
López, B., González, A., Hermida, N., Valencia, F., de Teresa, E., & Díez, J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00335.2010 · Cited by 252
Saxena, A., Chen, W., Su, Y., Rai, V., Uche, O. U., Li, N., & Frangogiannis, N. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300725 · Cited by 252
Self-citationCirculating Biomarkers of Collagen Metabolism in Cardiac Diseases
López, B., González, A., & Díez, J. (2010) · Circulation · doi:10.1161/circulationaha.109.912774 · Cited by 252
Ashizawa, N., Graf, K., Do, Y. S., Nunohiro, T., Giachelli, C. M., Meehan, W. P., Tuan, T. L., & Hsueh, W. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119031 · Cited by 251
Zhao, L., Cheng, G., Jin, R., Afzal, M. R., Samanta, A., Xuan, Y.-T., Girgis, M., Elias, H. K., Zhu, Y., Davani, A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308688 · Cited by 251
Yamamoto, T., Eckes, B., Mauch, C., Hartmann, K., & Krieg, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6174 · Cited by 250
Wnt and the Wnt signaling pathway in bone development and disease
Wang, Y. (2014) · Frontiers in Bioscience · doi:10.2741/4214 · Cited by 248
Essential role for premature senescence of myofibroblasts in myocardial fibrosis
Meyer, K., Hodwin, B., Ramanujam, D., Engelhardt, S., & Sarikas, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.047 · Cited by 247
Ohkubo, N., Matsubara, H., Nozawa, Y., Mori, Y., Murasawa, S., Kijima, K., Maruyama, K., Masaki, H., Tsutumi, Y., Shibazaki, Y., et al. (1997) · Circulation · doi:10.1161/01.cir.96.11.3954 · Cited by 246 · cited 1×
“In contrast, the type 2 receptor AT2 acts as a negative regulator of angiotensin II-mediated fibrogenic responses, inhibiting AT1 actions and suppressing fibroblast proliferation and matrix synthesis.(83,84)”
BackgroundMechanical Forces in Cutaneous Wound Healing: Emerging Therapies to Minimize Scar Formation
Barnes, L. A., Marshall, C. D., Leavitt, T., Hu, M. S., Moore, A. L., Gonzalez, J. G., Longaker, M. T., & Gurtner, G. C. (2018) · Advances in Wound Care · doi:10.1089/wound.2016.0709 · Cited by 246
Crabos, M., Roth, M., Hahn, A. W., & Erne, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117243 · Cited by 245 · cited 1×
“In vitro studies have demonstrated that angiotensin II stimulates cardiac fibroblast proliferation,(75) inhibits fibroblast apoptosis,(76) stimulates fibroblast migration(77,78) inducing integrin expression,(79) promotes myofibroblast conversion,(80) and markedly increases synthesis of structural ECM proteins.(81,82)…”
BackgroundAnoïkis in the Cardiovascular System: Known and Unknown Extracellular Mediators
Michel, J.-B. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000099882.52647.e4 · Cited by 245
The regenerative capacity of the zebrafish heart is dependent on TGFβ signaling
Chablais, F., & Jaźwińska, A. (2012) · Development · doi:10.1242/dev.078543 · Cited by 241
Osteopontin Expression Is Required for Myofibroblast Differentiation
Lenga, Y., Koh, A., Perera, A. S., McCulloch, C. A., Sodek, J., & Zohar, R. (2008) · Circulation Research · doi:10.1161/circresaha.107.160408 · Cited by 241
Hayashidani, S., Tsutsui, H., Shiomi, T., Ikeuchi, M., Matsusaka, H., Suematsu, N., Wen, J., Egashira, K., & Takeshita, A. (2003) · Circulation · doi:10.1161/01.cir.0000092890.29552.22 · Cited by 240
Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts
Booz, G. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(96)88507-5 · Cited by 237
Schelbert, E. B., Piehler, K. M., Zareba, K. M., Moon, J. C., Ugander, M., Messroghli, D. R., Valeti, U. S., Chang, C. H., Shroff, S. G., Diez, J., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002613 · Cited by 237
IL-33/ST2 Axis in Organ Fibrosis
Kotsiou, O. S., Gourgoulianis, K. I., & Zarogiannis, S. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02432 · Cited by 232 · cited 1×
“IL-33, another member of the IL-1 family of cytokines has been implicated in the regulation of fibrosis in several different organs.(175) In”
BackgroundThe Role of Platelet-Derived Growth Factor Signaling in Healing Myocardial Infarcts
Zymek, P., Bujak, M., Chatila, K., Cieslak, A., Thakker, G., Entman, M. L., & Frangogiannis, N. G. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.060 · Cited by 231 · cited 2×
“model of reperfused MI, treatment with a neutralizing anti-PDGFR-a antibody attenuated collagen deposition.(256) Moreover, in pressure-”
BackgroundMethodSelf-citationFrangogiannis, N. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00158-9 · Cited by 230 · cited 1×
“Original data published in ref.(30) Cardiac fibrosis 1453”
BackgroundSelf-citationCMR-Verified Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction in HFpEF
Su, M.-Y. M., Lin, L.-Y., Tseng, Y.-H. E., Chang, C.-C., Wu, C.-K., Lin, J.-L., & Tseng, W.-Y. I. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.04.022 · Cited by 229
The collagen matrix of the heart.
Borg, T. K., & Caulfield, J. (1981) · PubMed · Cited by 226
Swaney, J. S., Roth, D. M., Olson, E. R., Naugle, J. E., Meszaros, J. G., & Insel, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408704102 · Cited by 226
Matricryptins and matrikines: biologically active fragments of the extracellular matrix
Ricard‐Blum, S., & Salza, R. (2014) · Experimental Dermatology · doi:10.1111/exd.12435 · Cited by 224
Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization
Eghbali, M. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)91498-3 · Cited by 222
Mechanical regulation of gene expression in cardiac myocytes and fibroblasts
Saucerman, J. J., Tan, P. M., Buchholz, K. S., McCulloch, A. D., & Omens, J. H. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0155-8 · Cited by 221
Schelbert, E. B., Fridman, Y., Wong, T. C., Abu Daya, H., Piehler, K. M., Kadakkal, A., Miller, C. A., Ugander, M., Maanja, M., Kellman, P., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2511 · Cited by 219
Turner, N. A. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.002 · Cited by 216 · cited 1×
“environmental changes and typically respond to injurious stimuli by activating inflammatory and fibrogenic programmes.(67) It should be emphasized that the actions of leucocytes, vascular cells and cardiomyo-”
BackgroundChirinos, J. A., Orlenko, A., Zhao, L., Basso, M. D., Cvijic, M. E., Li, Z., Spires, T. E., Yarde, M., Wang, Z., Seiffert, D. A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.069 · Cited by 216
Adapala, R. K., Thoppil, R. J., Luther, D. J., Paruchuri, S., Meszaros, J. G., Chilian, W. M., & Thodeti, C. K. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.10.016 · Cited by 215
Li, R.-K., Li, G., Mickle, D. A. G., Weisel, R. D., Merante, F., Luss, H., Rao, V., Christakis, G. T., & Williams, W. G. (1997) · Circulation · doi:10.1161/01.cir.96.3.874 · Cited by 211 · cited 1×
“TGF-b induction and activation has been consistently demonstrated in several different models of cardiac fibrosis,(205,213,214) and in human hearts with fibrotic cardiomyopathic changes.(215,216) Although many different cell types (including macrophages, fibroblasts, cardiomyocytes, and platelets) can produce de novo…”
BackgroundMarijianowski, M. M. H., Teeling, P., Mann, J., & Becker, A. E. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00557-7 · Cited by 210
Cited by
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
“Cardiac fibroblast can sense mechanical cues through mechanosensitive receptors, and channels, hence promoting intracellular fibrogenic signaling.(634) Previous studies demonstrated that cyclic stretch promotes fibroblast activation and FMT.”
BackgroundMacrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 349
Antar, S. A., Ashour, N. A., Marawan, M. E., & Al-Karmalawy, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044004 · Cited by 366
“Cardiac fibrosis is an aberrant thickening of the heart valves caused by unsuitable fibroblast proliferation, but it is more frequently used to describe the excessive deposition of ECM in the cardiac muscle, as described in Figure 12 [123].”
BackgroundGoette, A., Corradi, D., Dobrev, D., Aguinaga, L., Cabrera, J.-A., Chugh, S. S., de Groot, J. R., Soulat-Dufour, L., Fenelon, G., Hatem, S. N., et al. (2024) · Europace · doi:10.1093/europace/euae204 · Cited by 310
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Metadata
- Authors
- Frangogiannis, N. G.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Frangogiannis, Nikolaos G
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-02
- Volume
- 117
- Issue
- 6
- Pages
- 1450-1488
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC8152700
- OpenAlex
- W4210607007
- Cited by
- 1,229
- References
- 615
- Citations by year
- 2026: 265 · 2025: 319 · 2024: 273 · 2023: 210 · 2022: 130 · 2021: 32
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Cardiovascular Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R01 HL76246, R01 HL85440, R01 HL149407)
- U.S. Department of Defense (PR151134, PR151029, PR181464)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- myocardial fibrosis, myocardial fibroblasts, myofibroblasts, extracellular matrix deposition, TGF-beta, platelet-derived growth factor, cytokines, mechanoreceptors, integrins, pressure overload, myocardial infarction, heart failure, familial cardiomyopathy, diabetic cardiomyopathy, cardiac arrhythmias
- MeSH terms
- Antifibrotic Agents, Animals, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Cardiomyopathies, Myocytes, Cardiac, Mechanotransduction, Cellular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.